Spero Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Spero Therapeutics, Inc. (SPRO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 3.57 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 3.57M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 3.52M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 2.40M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 2.40M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2026-06-30 | 3.57M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 3.52M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 2.40M shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 2.40M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 2.58M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 2.64M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 2.81M shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 2.86M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 2.86M shares 10-Q · filed 2024-08-05 |
| 2024-03-31 | 2.88M shares 10-Q · filed 2024-05-15 |
| 2023-12-31 | 2.87M shares 10-K · filed 2024-03-13 |
| 2023-09-30 | 2.92M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 3.73M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 4.00M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 3.98M shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 4.02M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 4.62M shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 5.78M shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 4.89M shares 10-K · filed 2022-03-31 |
| 2021-09-30 | 4.75M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 4.58M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 4.58M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 3.68M shares 10-K · filed 2021-03-11 |
| 2020-09-30 | 3.68M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 3.67M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 3.65M shares 10-Q · filed 2020-05-08 |
| 2019-12-31 | 2.97M shares 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |